Skip to main content
SpringerLink
Log in
Book cover

Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel pp 207–213Cite as

Fettgewebsdysfunktion

  • Chapter
  • First Online:

  • 3809 Accesses

Zusammenfassung

Erläutert werden alle relevanten Funktionstests mit ausführlicher Darstellung von Indikationen, Kontraindikationen, Nebenwirkungen, Testvorbereitung, Rahmenbedingungen, konkreten Handlungsanleitung der eigentlichen Testdurchführung sowie der Interpretation der Testergebnisse. Es werden immer konkrete Normbereiche und Cut-off-Werte angegeben, auch für besondere Situationen (Geschlecht, Alter, BMI, Pubertätsphasen, Zyklusphasen, akute Erkrankungen, Medikamente etc.). Ein besonderes Merkmal ist die Betonung der Testvorbereitung, -durchführung und -interpretation sowie des interdisziplinären Charakters. Dieses Kapitel fasst Parameter der Fettgewebsdysfunktion, Fettgewebshormone, anthropometrische Messgrößen und die Bioimpedanzanalyse zusammen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  1. Longo DL, Fauci AS, Kasper DL, Hauser SL (2011) Harrison’s principles of internal medicine. McGraw-Hill Professional, Maidenhead

    Google Scholar 

  2. James WPT (1976) Research on obesity. Her Majesty’s Stationary Office, London

    Google Scholar 

  3. Hallynck TH, Soep HH, Thomis JA, Boelaert J, Daneels R, Dettli L (1981) Should clearance be normalised to body surface or to lean body mass? Br J Clin Pharmacol 11:523–526

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Durnin JV, Womersley J (1974) Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 32:77–97

    Article  CAS  PubMed  Google Scholar 

  5. Berres F, Ulmer HV, Lamberty M (1980) Calculation of total body fat from skinfold thickness by using an age corrected formula. Pflugers Arch 384(Suppl):R35

    Google Scholar 

  6. von Restorff W (2004) Leitlinien der Deutschen Gesellschaft für Arbeitsmedizin und Umweltmedizin e.V. (DGAUM). https://www.dgaum.de/leitlinien-qualitaetssicherung. Zugegriffen am 01.02.2018

  7. Schäffler A, Müller-Ladner U, Schölmerich J, Büchler C (2006) Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev 27:449–467

    Article  PubMed  Google Scholar 

  8. Beltowski J (2003) Adiponectin and resistin – new hormones of white adipose tissue. Med Sci Monit 9:RA55–RA61

    CAS  PubMed  Google Scholar 

  9. Bowles L, Kopelman P (2001) Leptin: of mice and men? J Clin Pathol 54:1–3

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV (1996) Leptin: the tale of an obesity gene. Diabetes 45:1455–1462

    Article  CAS  PubMed  Google Scholar 

  11. Chan JL, Mantzoros CS (2005) Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet 366:74–85

    Article  CAS  PubMed  Google Scholar 

  12. Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS (2010) Leptin in human physiology and therapeutics. Front Neuroendocrinol 31:377–393

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Kelesidis T, Mantzoros CS (2006) The emerging role of leptin in humans. Pediatr Endocrinol Rev 3:239–248

    PubMed  Google Scholar 

  14. Cui J, Panse S, Falkner B (2011) The role of adiponectin in metabolic and vascular disease: a review. Clin Nephrol 75:26–33

    CAS  PubMed  Google Scholar 

  15. Haluzik M, Parizkova J, Haluzik MM (2004) Adiponectin and its role in the obesity-induced insulin resistance and related complications. Physiol Res/Academia Scientiarum Bohemoslovaca 53:123–129

    CAS  Google Scholar 

  16. Han SH, Quon MJ, Kim JA, Koh KK (2007) Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 49:531–538

    Article  CAS  PubMed  Google Scholar 

  17. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451

    Article  CAS  PubMed  Google Scholar 

  18. Koerner A, Kratzsch J, Kiess W (2005) Adipocytokines: leptin – the classical, resistin – the controversical, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19:525–546

    Article  CAS  PubMed  Google Scholar 

  19. Haluzik M, Haluzikova D (2006) The role of resistin in obesity-induced insulin resistance. Curr Opin Investig Drugs 7:306–311

    CAS  PubMed  Google Scholar 

  20. Barnes KM, Miner JL (2009) Role of resistin in insulin sensitivity in rodents and humans. Curr Protein Pept Sci 10:96–107

    Article  CAS  PubMed  Google Scholar 

  21. Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ (2011) Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review. Diabetes/Metab Res Rev 27:515–527

    Article  Google Scholar 

  22. Sonoli SS, Shivprasad S, Prasad CV, Patil AB, Desai PB, Somannavar MS (2011) Visfatin – a review. Eur Rev Med Pharmacol Sci 15:9–14

    CAS  PubMed  Google Scholar 

  23. Castaneda TR, Tong J, Datta R, Culler M, Tschop MH (2010) Ghrelin in the regulation of body weight and metabolism. Front Neuroendocrinol 31:44–60

    Article  CAS  PubMed  Google Scholar 

  24. Al Massadi O, Tschop MH, Tong J (2011) Ghrelin acylation and metabolic control. Peptides 32:2301–2308

    Article  PubMed  Google Scholar 

  25. Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A (2009) Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev 61:430–481

    Article  CAS  PubMed  Google Scholar 

  26. Tan BK, Adya R, Randeva HS (2010) Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med 20:143–148

    Article  CAS  PubMed  Google Scholar 

  27. Ernst MC, Sinal CJ (2010) Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 21:660–667

    Article  CAS  PubMed  Google Scholar 

  28. Bluher M (2011) Vaspin in obesity and diabetes: pathophysiological and clinical significance. Endocrine 41:176–182

    Article  PubMed  Google Scholar 

  29. Compton SA, Cheatham B (2010) CTRP-3: blocking a toll booth to obesity-related inflammation. Endocrinology 151:5095–5097

    Article  CAS  PubMed  Google Scholar 

  30. Pfützner A, Forst T, Rancier M, Weryha G (2011) Metabolisches syndrom. Clinical and technical review. TECO medical Group, 1–31. https://www.dgaum.de/umweltmedizin. Zugegriffen am 01.02.2018

  31. El-Mesallamy HO, El-Derany MO, Hamdy NM (2011) Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med 28:1194–1200

    Article  CAS  PubMed  Google Scholar 

  32. Akbarzadeh S, Nabipour I, Jafari SM, Movahed A, Motamed N, Assadi M, Hajian N (2012) Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 95:132–138

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Innere Medizin III, Universitätsklinikum Gießen und Marburg (UKGM), Standort Giessen, Giessen, Deutschland

    Andreas Schäffler & Thomas Karrasch

  2. Lehrstuhl für Geriatrie, Universitätsklinikum Aachen, Universität Aachen, Aachen, Deutschland

    Cornelius Bollheimer

  3. Abteilung für Innere Medizin, Caritas Krankenhaus St. Josef, Regensburg, Regensburg, Deutschland

    Roland Büttner

  4. Klinik für Allgemeine Innere Medizin und Geriatrie, Krankenhaus der Barmherzigen Brüder, Regensburg, Deutschland

    Christiane Girlich

  5. Institut für Klinische Chemie und Laboratoriumsmedizin, Klinikum der Universität Regensburg, Regensburg, Deutschland

    Charalampos Aslanidis

  6. Institut für Pathologie, Klinikum der Universität Regensburg, Regensburg, Deutschland

    Wolfgang Dietmaier

  7. Medizinische Klinik und Poliklinik I, Universitätsklinikum Würzburg, Würzburg, Deutschland

    Margarita Bala

  8. Abteilung für Innere Medizin, Klinikum Bogen, Bogen, Deutschland

    Viktoria Guralnik

  9. Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg, Regensburg, Deutschland

    Sylvia Schneider

Authors
  1. Andreas Schäffler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cornelius Bollheimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roland Büttner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Christiane Girlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Charalampos Aslanidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wolfgang Dietmaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Margarita Bala
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Viktoria Guralnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Thomas Karrasch
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Sylvia Schneider
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Schäffler .

Editor information

Editors and Affiliations

  1. Medizinische Klinik und Poliklinik III, Universitätsklinikum Gießen und Marburg (UKGM), Standort Gießen, Gießen, Germany

    Andreas Schäffler

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Deutschland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Schäffler, A. et al. (2018). Fettgewebsdysfunktion. In: Schäffler, A. (eds) Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55914-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-55914-7_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-55913-0

  • Online ISBN: 978-3-662-55914-7

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation